Immunostimulatory colloidal delivery systems for cancer vaccines. (Q36460849)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16640495 AND SRC:MED&resulttype=core&format=json

20 January 2020

title

Immunostimulatory colloidal delivery systems for cancer vaccines (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16640495 AND SRC:MED&resulttype=core&format=json

20 January 2020

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16640495 AND SRC:MED&resulttype=core&format=json

20 January 2020

author name string

Anne Saupe

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16640495 AND SRC:MED&resulttype=core&format=json

20 January 2020

Warren McBurney

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16640495 AND SRC:MED&resulttype=core&format=json

20 January 2020

Sarah Hook

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16640495 AND SRC:MED&resulttype=core&format=json

20 January 2020

language of work or name

English

0 references

publication date

1 May 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16640495 AND SRC:MED&resulttype=core&format=json

Expert Opinion on Drug Delivery

20 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16640495 AND SRC:MED&resulttype=core&format=json

20 January 2020

volume

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16640495 AND SRC:MED&resulttype=core&format=json

20 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16640495 AND SRC:MED&resulttype=core&format=json

20 January 2020

page(s)

345-354

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16640495 AND SRC:MED&resulttype=core&format=json

Lipid based particulate formulations for the delivery of antigen.

20 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1517/17425247.3.3.345

DNA vaccination against tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17425247.3.3.345

TLR9 pathway is involved in adjuvant effects of plasmid DNA-based vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17425247.3.3.345

Immune recognition of self in immunity against cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17425247.3.3.345

Preparation of coated nanoparticles for a new mucosal vaccine delivery system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17425247.3.3.345

Targeting the innate immune response with improved vaccine adjuvants

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17425247.3.3.345

Vaccines that facilitate antigen entry into dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17425247.3.3.345

Aluminium compounds for use in vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17425247.3.3.345

In vivo absorption of aluminium-containing vaccine adjuvants using 26Al

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17425247.3.3.345

Aluminium adjuvants--in retrospect and prospect

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17425247.3.3.345

T regulatory cells 1 inhibit a Th2-specific response in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17425247.3.3.345

Vaccine adjuvants: current state and future trends

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17425247.3.3.345

Macrophagic myofasciitis lesions assess long-term persistence of vaccine-derived aluminium hydroxide in muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17425247.3.3.345

Aluminum inclusion macrophagic myofasciitis: a recently identified condition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17425247.3.3.345

Studies on the toxicities of aluminium hydroxide and calcium phosphate as immunological adjuvants for vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17425247.3.3.345

Using different structure types of microemulsions for the preparation of poly(alkylcyanoacrylate) nanoparticles by interfacial polymerization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17425247.3.3.345

Biodegradable poly(lactic-co-glycolic acid) microparticles for injectable delivery of vaccine antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17425247.3.3.345

Poly-D,L-lactide-co-poly(ethylene glycol) microspheres as potential vaccine delivery systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17425247.3.3.345

Chitosan as a novel nasal delivery system for vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17425247.3.3.345

Recent advances on chitosan-based micro- and nanoparticles in drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17425247.3.3.345

Effect of molecular weight heterogeneity on drug encapsulation efficiency of gelatin nano-particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17425247.3.3.345

Review of novel particulate antigen delivery systems with special focus on treatment of type I allergy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17425247.3.3.345

Solvent Evaporation Processes for the Production of Controlled Release Biodegradable Microsphere Formulations for Therapeutics and Vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17425247.3.3.345

An investigation of the factors controlling the adsorption of protein antigens to anionic PLG microparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17425247.3.3.345

Enhanced antigen presentation and immunostimulation of dendritic cells using acid-degradable cationic nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17425247.3.3.345

A macromolecular delivery vehicle for protein-based vaccines: acid-degradable protein-loaded microgels

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17425247.3.3.345

Phagocytosis of latex particles by leucocytes. I. Dependence of phagocytosis on the size and surface potential of particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17425247.3.3.345

Particle size and surface charge affect particle uptake by human dendritic cells in an in vitro model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17425247.3.3.345

Analysis of poly(D,L-lactic-co-glycolic acid) nanosphere uptake by human dendritic cells and macrophages in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17425247.3.3.345

Recent developments in adjuvants for vaccines against infectious diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17425247.3.3.345

Nanoparticle and targeted systems for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17425247.3.3.345

Anionic microparticles are a potent delivery system for recombinant antigens from Neisseria meningitidis serotype B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17425247.3.3.345

Poly(?-lactide-co-glycolide)-encapsulated plasmid DNA elicits systemic and mucosal antibody responses to encoded protein after oral administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17425247.3.3.345

Repeated immunization with plasmid DNA formulated in poly(lactide-co-glycolide) microparticles is well tolerated and stimulates durable T cell responses to the tumor-associated antigen cytochrome P450 1B1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17425247.3.3.345

Immune stimulating activity of two new chitosan containing adjuvant formulations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17425247.3.3.345

Preparation, characterization and biodistribution of ultrafine chitosan nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17425247.3.3.345

Novel chitosan particles and chitosan-coated emulsions inducing immune response via intranasal vaccine delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17425247.3.3.345

Enhancement of the effectiveness of electroporation-augmented cutaneous DNA vaccination by a particulate adjuvant

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17425247.3.3.345

Liposomes and virosomes as delivery systems for antigens, nucleic acids and drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17425247.3.3.345

Immunogenicity and protectivity of a new liposomal hepatitis A vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17425247.3.3.345

Formulation and biopharmaceutical issues in the development of drug delivery systems for antiparasitic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17425247.3.3.345

Soluble proteins delivered to dendritic cells via pH-sensitive liposomes induce primary cytotoxic T lymphocyte responses in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17425247.3.3.345

Incorporation of ovalbumin into ISCOMs and related colloidal particles prepared by the lipid film hydration method

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17425247.3.3.345

Liposome oligomannose-coated with neoglycolipid, a new candidate for a safe adjuvant for induction of CD8 cytotoxic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17425247.3.3.345

Biodistribution and tumor localization of stealth liposomal tumor necrosis factor-alpha in soft tissue sarcoma bearing rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17425247.3.3.345

Special methods for the analysis of ether lipid structure and metabolism in archaea

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17425247.3.3.345

Archaeosome vaccine adjuvants induce strong humoral, cell-mediated, and memory responses: comparison to conventional liposomes and alum

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17425247.3.3.345

Iscom, a novel structure for antigenic presentation of membrane proteins from enveloped viruses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17425247.3.3.345

Internalization of iscom-borne antigens and presentation under MHC class I or class II restriction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17425247.3.3.345

ISCOMs and other saponin based adjuvants

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17425247.3.3.345

A comparison of pseudo-ternary diagrams of aqueous mixtures of Quil A, cholesterol and phospholipid prepared by lipid-film hydration and dialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17425247.3.3.345

Quil A-lipid powder formulations releasing ISCOMs and related colloidal structures upon hydration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17425247.3.3.345

Immuno-stimulating complexes prepared by ethanol injection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17425247.3.3.345

Delivery of protein antigens to the immune system by fusion-active virosomes: a comparison with liposomes and ISCOMs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17425247.3.3.345

Current status and potential application of ISCOMs in veterinary medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17425247.3.3.345

ISCOM based vaccines for cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17425247.3.3.345

Host, viral, and vaccine factors that determine protective efficacy induced by rotavirus and virus-like particles (VLPs).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17425247.3.3.345

Tumor progression can occur despite the induction of very high levels of self/tumor antigen-specific CD8 T cells in patients with melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17425247.3.3.345

Induction of humoral and CD8 T cell responses are required for protection against lethal Ebola virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17425247.3.3.345

Interaction of papillomavirus virus-like particles with human myeloid antigen-presenting cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17425247.3.3.345

Analysis of protein expression and virus-like particle formation in mammalian cell lines stably expressing HIV-1 gag and env gene products with or without active HIV proteinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17425247.3.3.345

A block in virus-like particle maturation following assembly of murine leukaemia virus in insect cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17425247.3.3.345

Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17425247.3.3.345

Cancer immunotherapy: moving beyond current vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17425247.3.3.345

Recombinant NY-ESO-1 protein with ISCOMATRIX adjuvant induces broad integrated antibody and CD4 and CD8 T cell responses in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17425247.3.3.345

Fine particles of widely different composition have an adjuvant effect on the production of allergen-specific antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17425247.3.3.345

In interleukin-4-deficient mice, alum not only generates T helper 1 responses equivalent to Freund's complete adjuvant, but continues to induce T helper 2 cytokine production

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17425247.3.3.345

Interleukin-18 plays a role in both the alum-induced T helper 2 response and the T helper 1 response induced by alum-adsorbed interleukin-12

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17425247.3.3.345

Immune complement activation on polystyrene and silicon dioxide surfaces. Impact of reversible IgG adsorption

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17425247.3.3.345

Present and future of cancer vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17425247.3.3.345

Immunization by particle-mediated transfer of the granulocyte-macrophage colony-stimulating factor gene into autologous tumor cells in melanoma or sarcoma patients: report of a phase I/IB study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17425247.3.3.345

Protection against experimental Aeromonas salmonicida infection in carp by oral immunisation with bacterial antigen entrapped liposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17425247.3.3.345

Human autologous tumor-specific T-cell responses induced by liposomal delivery of a lymphoma antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17425247.3.3.345

Encapsulation of lipopeptides within liposomes: effect of number of lipid chains, chain length and method of liposome preparation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17425247.3.3.345

Non-invasive vaccine delivery in transfersomes, niosomes and liposomes: a comparative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17425247.3.3.345

Lymphatic uptake and biodistribution of liposomes after subcutaneous injection: III. Influence of surface modification with poly(ethyleneglycol)

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17425247.3.3.345

Liposomes containing interferon-gamma as adjuvant in tumor cell vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17425247.3.3.345

Randomized phase IIB trial of BLP25 liposome vaccine in stage IIIB and IV non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17425247.3.3.345

Archaeobacterial ether lipid liposomes as vaccine adjuvants

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17425247.3.3.345

21 January 2018

Identifiers

DOI

10.1517/17425247.3.3.345

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16640495 AND SRC:MED&resulttype=core&format=json

20 January 2020

1 reference